Dr. Maxwell received his PhD in Molecular Virology at the University of Texas Graduate School of Biomedical Sciences in Houston in 1986. He did post-doctoral studies in the laboratories of Drs. Gary Gallick and Janet Butel at M.D. Anderson Cancer Center and Baylor College of Medicine, respectively, from 1986-1990. Dr. Maxwell was an assistant professor in the Department of Thoracic Surgery at M.D. Anderson Cancer Center before moving to the Texas A&M Health Science Center in 1995. He currently is an associate professor in the department of Molecular & Cellular Medicine at the Texas A&M Health Science Center.
Dr. Maxwell’s research is in the field of cancer drug resistance. In particular, he studies mechanisms of chemoresistance in lymphoma and ovarian carcinoma. Dr. Maxwell has also participated in the development of a new class of chemosensitizer that reverses drug resistance in many different types of cancers.
